× Industry Reports Services Press Release Contact us About us

North American Stents Market revenue to cross $2.8 Bn by 2027

 Request a sample

North American Stents Market size is expected to cross USD 2.8 billion by 2027, according to a latest forecast report by Graphical Research. Presence of large number of manufacturers in the region will spur the market expansion.

Technological advancement is one of the major factors driving the market growth. Technological advancement in coronary stents is increasing as the companies are investing in product development and various partnership of strategic collaborations. Development in bifurcated stents and use of biodegradable materials have increased the use of stents in cardiovascular treatment.

Growing number of minimally invasive surgeries will boost the market demand in the region. Various advantages such as smaller inclusion wounds, shorter hospital stay, and fast recovery increases the demand of the minimally invasive surgeries. However, product recall and stringent regulatory scenario in developed countries may restrain the market size. 

Based on product, the North American stents market is segmented into vascular stents and non-vascular stents. Vascular stents segment accounted for USD 2.5 billion in 2020. Peripheral stents are implanted in conjunction with balloon angioplasty. It is used to hold open an artery so that blood can flow through the clogged or blocked artery.

Based on material, the market is bifurcated into metal and polymer. The polymer stents segment will show a significant growth of 2.2% from 2021 to 2027 due to growing utilization of polymers for development of bioabsorbable stents. Polymers are widely used in application of coronary vascular intervention as stent platforms and coating matrices for drug eluting stents.

Browse detailed statistical insights from the report, “North America Stents Market Size, By Type (Self-expandable, Balloon-expandable), By Material (Metal, Polymer), By Product (Vascular Stents {Coronary Stents [Bare Metal Stents, Drug Eluting Stents, Bioresorbable Stents], Peripheral Stents [Iliac, Femoral-popliteal, Renal, Carotid], Neurovascular Stents}, Non-Vascular Stents), By End-use (Hospital, Ambulatory Surgical Centers), Research Report, Country Outlook (Japan, China, India, Australia, Singapore, South Korea, Malaysia, Thailand, Philippines, Indonesia), Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2021 - 2027” along with the table of contents (ToC) @

https://www.graphicalresearch.com/industry-insights/1643/north-america-stents-market

Based on type, the market is segmented into self-expandable and balloon-expandable stents. Balloon expandable stents segment is set to surpass USD 1.8 billion by 2027 owing to increasing research activities by various companies to improve technology and high utilization of these stents. Growing regulatory approvals for balloon expandable stents will propel the segment growth.

On the basis of end-use, the North American market is divided into hospital, ambulatory surgical center and others. The hospital segment held revenue of USD 2.1 billion in 2020. Cost effective treatment provided by various government hospitals will propel the market growth. Well-equipped medical facilities and infrastructure is growing the preference of consumers towards hospitals. Additionally, availability of skilled healthcare professionals will spur the segment growth.

The Canada stents market will register a growth of 3.9% through 2027. High utilization of coronary stents will drive the growth of the stents in the country. Hospitals are well equipped with many medical devices that includes stents. This stent are essential devices that are used during minimally invasive surgical procedures.

Major market players operating in stents market are Abbott Laboratories, Boston Scientific Corporation and Medtronic, among others. These market players focusing on various business strategies such as collaboration, geographic expansion to strengthen their market position. For instance, in April 2017, Boston Scientific Corporation received Canadian Approval for Taxus Liberte Stent System. This approval enabled the company to increase its revenue.

The North American stents market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2016 to 2027, for the following segments:

North America Market, By Product

  • Vascular stents
    • Coronary stents
      • Bare metal stents
      • Drug eluting stents
      • Bioresorbable stents
    • Peripheral stents
      • Iliac
      • Femoral-popliteal
      • Renal
      • Carotid
    • Neurovascular stents
  • Non-vascular Stents

North America Market, By Material

  • Metal
  • Polymer

North America Market, By Type

  • Self-expandable
  • Balloon expandable

North America Market, By End-Use

  • Hospitals
  • Ambulatory surgical centers
  • Other

The above information is provided for the following countries:

  • North America
    • U.S.
    • Canada